Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

ABSI vs GOCO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABSI Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–1 Matrix Metrics)

ABSI Overall Winner 6-Pillar Tally: ABSI 3 – 2 GOCO (1 Tie) Matrix Metrics: ABSI 7 – 1 GOCO

As of Nov 17, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). ABSI carries a Unified Composite Score of 50.8/100 (HOLD) at $7.55 (N/M Forward P/E, -9108.3% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin).

  • Technical & Structure Timing Caution: ABSI is currently in a Breakdown options structure phase (RSI 38.4); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABSI vs GOCO
ABSI NASDAQ Head-to-Head Winner
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.55
+1.0% 1D
Market Cap $1.5B
TTM Revenue $1.5M
Forward P/E N/M
Beta / 30D Vol 3.31β · 126% Vol
Unified Composite Score
50.8 / 100 HOLD
Tech 50.0 Fund 56.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.4 · SMA20: $9.85 · SMA50: $9.60
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88

6-Pillar Scorecard Institutional Category Breakdown (ABSI 3 – 2 GOCO)

Columns: Metric · ABSI · GOCO
1. Valuation Multiples GOCO
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.1x
2. Growth & Scale ABSI
Revenue Growth (YoY) -19.6% -94.6%
Earnings Growth (YoY) +0.0% +424.1%
TTM Revenue (USD) $1.5M $153M
Market Cap $1.5B $8.5M
3. Profitability & Quality GOCO
Gross Margin N/A 57.3%
Operating Margin -9108.3% -292.0%
Net Profit Margin 0.0% -189.7%
Return on Equity (ROE) -58.6% -289.9%
4. Balance Sheet & Cash Flow ABSI
Cash Generation (TTM) -$112M -$148M EBITDA
Cash Flow Margin N/A -96.9% EBITDA Mgn
Net Cash / Leverage $10M Net Cash $0.13 Book/Sh · -289.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABSI
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 169.1% (15th %ile) N/A (N/A)
Put/Call OI Skew 1.21x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABSI (7) vs GOCO (1)
Institutional Metric ABSI GOCO Criterion Row Edge
Market Capitalization
Scale
$1.5B $8.5M Larger Scale ABSI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-19.6% -94.6% Higher Growth ABSI
Operating Margin (TTM)
Profitability
-9108.3% -292.0% Higher Margin GOCO
Net Profit Margin
Profitability
0.0% -189.7% Higher Margin ABSI
Return on Equity (ROE)
Capital Efficiency
-58.6% -289.9% Higher ROE ABSI
52-Week Range Position
Momentum
52% ($2–$13) 0% ($0–$7) Stronger Trend ABSI
Beta / 30D Volatility
Risk Regime
3.31β · 126% Vol 2.15β · 201% Vol Lower Realized Risk ABSI
Unified Institutional Score
Composite Signal
50.8 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite ABSI
Trailing 12M Revenue (USD)
Operating Scale
$1.5M $153M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 57.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$112M ($10M Net Cash) -$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABSI +95.92 pp
ABSI: +31.23% · GOCO: -64.69%
3M Horizon ABSI +272.32 pp
ABSI: +190.8% · GOCO: -81.52%
6M Horizon ABSI +179.88 pp
ABSI: +89.32% · GOCO: -90.56%
1Y Horizon ABSI +245.77 pp
ABSI: +157.8% · GOCO: -87.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABSI vs GOCO. Trailing 12-month operating profitability (ABSI -9108.3% vs GOCO -292.0%) and valuation multiples (ABSI N/M vs GOCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ABSI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.5M
Gross MarginN/A
Op. Margin-9108.3%
ROE / Fwd P/E-58.6% · N/M
GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABSI BREAKDOWN
98d in phase · OBV NEUTRAL
Current IV 169.1%
IV Percentile 15th %ile
Put/Call OI Skew 1.21x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABSI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.5B market capitalization and -9108.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ABSI vs GOCO Key Questions & Quantitative Answers

As of Nov 17, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). ABSI carries a Unified Composite Score of 50.8/100 (HOLD) at $7.55 (N/M Forward P/E, -9108.3% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin). Technical & Structure Timing Caution: ABSI is currently in a Breakdown options structure phase (RSI 38.4); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABSI leads the Growth & Scale pillar: ABSI posts -19.6% YoY revenue growth and +0.0% YoY earnings growth on $1.5M TTM revenue (N/A gross margin, -9108.3% operating margin), compared with GOCO at -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin). On trailing 12-month operating scale, ABSI generates $1.5M in USD-normalized revenue versus $153M for GOCO. In operating R&D and SG&A reinvestment, ABSI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GOCO.

GOCO screens cheaper on headline valuation multiples. ABSI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABSI (-58.6% ROE) versus GOCO (-289.9% ROE) capital efficiency.

In options market volatility and institutional positioning, ABSI carries 169.1% implied volatility (15th %ile, Compressed (<25th %ile)), a 1.21x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.31β · 126% Vol realized risk). By comparison, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.